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Abstract
Type 1 fimbriae are a crucial factor for the virulence of uropathogenic Escherichia coli during the first steps of infection by
mediating adhesion to epithelial cells. They are also required for the consequent colonization of the tissues and for invasion
of the uroepithelium. Here, we studied the role of the specialized signal transduction system CRP-cAMP in the regulation of
type 1 fimbriation. Although initially discovered by regulating carbohydrate metabolism, the CRP-cAMP complex controls a
major regulatory network in Gram-negative bacteria, including a broad subset of genes spread into different functional
categories of the cell. Our results indicate that CRP-cAMP plays a dual role in type 1 fimbriation, affecting both the phase
variation process and fimA promoter activity, with an overall repressive outcome on fimbriation. The dissection of the
regulatory pathway let us conclude that CRP-cAMP negatively affects FimB-mediated recombination by an indirect
mechanism that requires DNA gyrase activity. Moreover, the underlying studies revealed that CRP-cAMP controls the
expression of another global regulator in Gram-negative bacteria, the leucine-responsive protein Lrp. CRP-cAMP-mediated
repression is limiting the switch from the non-fimbriated to the fimbriated state. Consistently, a drop in the intracellular
concentration of cAMP due to altered physiological conditions (e.g. growth in presence of glucose) increases the
percentage of fimbriated cells in the bacterial population. We also provide evidence that the repression of type 1 fimbriae
by CRP-cAMP occurs during fast growth conditions (logarithmic phase) and is alleviated during slow growth (stationary
phase), which is consistent with an involvement of type 1 fimbriae in the adaptation to stress conditions by promoting
biofilm growth or entry into host cells. Our work suggests that the metabolic sensor CRP-cAMP plays a role in coupling the
expression of type 1 fimbriae to environmental conditions, thereby also affecting subsequent attachment and colonization
of host tissues.
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Introduction
Bacteria have the ability to rapidly adapt to changes in the
environment, a feature that is important for survival and
multiplication both during colonization of host organisms and in
the environment. An efficient adaptation implies the ability to
sense external parameters and to transduce the perceived signals to
cellular regulators, which then incite adaptive changes in the
physiology of the cell. One form of signal transduction occurs via
cytoplasmatic secondary messenger systems, so-called alarmones,
which can mediate a rapid response. Alarmones are low molecular
mass, non-proteinaceous, enzymatically synthesized compounds.
Several modified nucleotides have been described to execute this
function in bacteria, among them the 39,59-cyclic adenosine
monophosphate (cAMP). cAMP is a ubiquitous molecule found in
both prokaryotes and eukaryotes. In bacteria, the activity of cAMP
was initially thought to be restricted to its role in catabolite
repression [1]. However, there is evidence for an extended role of
cAMP as sensory signal involved in global gene regulation in
bacteria [2–5]. The level of intracellular cAMP is modulated by
several environmental factors [6–8]. The cellular target for cAMP-
signaling is the cAMP receptor protein (CRP). Dimeric CRP in
complex with one molecule of cAMP exhibits DNA-binding
activity to sites located near promoter regions [9]. Thereby, CRP-
cAMP acts as a global regulator of gene expression by controlling
the expression of almost 200 operons in E. coli [10–12].
Type 1 fimbriae mediate attachment to both biotic and abiotic
surfaces and are involved in the early stages of biofilm formation
[13,14]. In E. coli, type 1 fimbriae play a crucial role during
urinary tract infections by mediating adhesion to mannose-
containing receptors on the uroepithelium and promoting the
formation of intracellular bacterial communities [15–17]. Those
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independent transcription units coding for the recombinases FimE
and FimB, and a polycistronic operon encoding the structural
components (FimA, FimF, FimG, and FimH) and a pilus assembly
system (FimC and FimD) [18,19]. Phase variable expression of the
fim operon is associated with the inversion of a 314-bp
chromosomal region, flanked by two 9-bp inverted repeats, that
contains the fimA promoter [20,21]. When the invertible element is
in the so-called ON orientation, the promoter is directed towards
the structural fim genes, thus allowing transcription, whereas
transcription is abolished in the inverted OFF orientation. The
inversion process is catalyzed by FimB and FimE, two members of
the tyrosine site-specific recombinase family [22,23].
Several regulators are involved in the fine modulation of the
expression of type 1 fimbriae by environmental conditions [24,25].
A proper supercoiling state of the DNA and the presence of
accessory proteins, such as the DNA binding proteins Lrp and
IHF, are essential features that affect the recombination process
and determine whether the cell is fimbriated or not [26–29]. Other
regulators such as RpoS, ppGpp, NanR and NagC modulate type
1 fimbriation mostly by altering the expression of the recombinases
that catalyze the recombination event [30–32]. Moreover, the
global regulator H-NS has been shown to affect type 1 fimbriation
both by regulating the expression of the recombinases and by
directly interacting with the fim invertible element [33,34]. Effects
on the expression of type 1 fimbriae in cya derivatives of E. coli K-
12, which are defective in cAMP synthesis, were reported earlier
[35]. However, different strains responded divergently upon
addition of exogenous cAMP in static cultures and it was not
clarified at what level the reported effects were operating. In this
work, we describe that CRP-cAMP represses type 1 fimbriation.
The dissection of the mechanism underlying the observed
phenomenon demonstrated that CRP-cAMP indirectly represses
FimB-mediated recombination during the phase variation process.
In contrast to many other regulators of the phase variation of type
1 fimbriae described, CRP-cAMP affects phase variation inde-
pendently of the levels of the recombinases. We propose a novel
model by which CRP-cAMP controls the type 1 fimbriation state
in the bacterial population by affecting DNA gyrase activity. In
addition, our studies led to the new discovery that Lrp expression
in E. coli is under the control of the CRP-cAMP complex.
Results/Discussion
Type 1 fimbriation in E. coli is enhanced by the lack of the
CRP-cAMP regulatory complex
For a successful colonization of hosts by bacteria, it is crucial
that the expression of bacterial surface structures, which mediate
the interaction with the host tissues, is finely regulated. In E. coli,
the CRP-cAMP complex has been shown to regulate the
production of several of those surface structures, such as flagella
or P-fimbriae [36–39]. Using a crp deletion mutant derivative of
the extensively studied uropathogenic E. coli (UPEC) isolate J96,
we further characterized the role of CRP-cAMP in the modulation
of the expression of those colonization factors. Confirming
previous data, the CRP-cAMP deficient derivatives were non-
motile and had lost the ability to cause mannose-resistant
haemagglutination (MRHA) (data not shown). Agglutination tests
using specific antisera against the Pap and Prs fimbriae, adhesins
that mediate MRHA, confirmed that the expression of those
fimbriae is strictly dependent on the presence of functional CRP-
cAMP in the cell (data not shown).
J96, as most of the UPEC isolates, also expresses type 1
fimbriae, which are essential for the adherence and invasion of the
bladder uroepithelium. The expression of type 1 fimbriae can be
detected by mannose-sensitive yeast agglutination (MSYA), which
attests the ability of type 1 fimbriated bacteria to bind to
mannosides-containing receptors on the surface of yeast cells. A
clear stimulation in the ability to cause MSYA was observed in the
J96crp strain as compared with wt when growing in various culture
media (LB, TBA, CFA, and TSA; data not shown). Semi-
quantitative MSYA, using serially diluted LB cultures, corrobo-
rated these results: agglutination of yeast cells was observed with a
higher dilution of the J96crp cell suspension (4-fold, i.e. containing
8-times less bacterial cells) as compared to wt (Table 1). These
results indicate that the deficiency in CRP-cAMP caused a
substantial increase in the expression of type 1 fimbriae on the cell
surface.
In UPEC, a regulatory crosstalk between fimbrial operons
occurs, which also affects the expression of type 1 fimbriae. It is
known that the UPEC-specific regulators PapB, SfaB, and FocB,
which are involved in the regulation of P-related, S-related, and
F1C-related fimbriae, respectively, have the ability to repress the
expression of type 1 fimbriae [40–42]. It has been described that




J96 fimJ96 1/2 1/8
VL751/pACYC184 fim
2 n.d. n.d.
VL751/pSH2 fimJ96 1/32 1/128
MG1655 fimMG1655 1/4 1/8
Bacterial cultures of the indicated strains (wt and crp) were grown in LB medium
overnight at 37uC with vigorous shaking. The origin of the fim determinant
present in each strain is indicated. The numeric values indicate the highest




Attachment of bacteria to the surface of host tissues is a
crucial initial step in the establishment of bacterial
infections. This process is mediated by adhesins, such as
the type 1 fimbriae of Escherichia coli, which play a key role
during urinary tract infections by mediating adhesion to
the uroepithelium. The expression of type 1 fimbriae is
finely regulated attending to environmental signals and is
under phase variation control, which determines the
percentage of fimbriated cells in the population. In this
report, we show that the expression of type 1 fimbriae is
repressed by a metabolic sensor of the cell, the global
regulatory complex CRP-cAMP. We demonstrate that CRP-
cAMP affects the switching outcome by selectively
inhibiting the recombination process in one direction
only, resulting in a lower percentage of fimbriated cells.
Such a switch to the non-fimbriated state after successful
adhesion might be advantageous in the urinary tract,
where the immune mechanisms of the host favor the
removal of bacteria expressing immunogenic surface
structures. Understanding the regulatory networks that
govern regulation of virulence and colonization factors is
both of basic interest and might help to develop novel
strategies to treat bacterial infections.
CRP-cAMP Regulation of Type 1 Fimbriae
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the P-related fimbriae and the PapB regulator [39]. Therefore, a
possible explanation for the observed increase in type 1 fimbriation
in the crp derivative could be the lack of expression of UPEC-
specific repressors of type 1 fimbriae such as PapB. To test this,
MSYA experiments were performed using wt and crp derivatives of
an E. coli K-12 strain, which lacks such regulators. The VL751
strain (mutant in the chromosomal fim gene cluster and
consequently deficient in type 1 fimbriation), carrying the entire
fim determinant of the J96 strain on the pACYC184-based plasmid
pSH2 was used. crp derivatives of this commensal strain expressing
the fimJ96 determinant had enhanced agglutination ability as
compared with the wt strain (Table 1). As expected, strains
carrying pACYC184 did not agglutinate yeast cells. Furthermore,
type 1 fimbriae expression was also monitored in the K-12 strain
MG1655 (fim
+) and its crp derivative, giving the same result
(Table 1). As a control, in all MSYA assays described, the
agglutination could be effectively blocked by the addition of
mannosides (data not shown). Since the up-regulation of type 1
fimbriation was observed in both UPEC and commensal isolates,
our results exclude the possibility that the CRP-cAMP effect
strictly requires any UPEC-specific factor or is solely due to
regulatory crosstalk between fimbrial operons, although we can
not rule out a possible contribution to the regulation in pathogenic
isolates.
CRP-cAMP plays a dual role in the transcriptional
regulation of type 1 fimbriae
The fimA gene encodes the major subunit of the type 1 fimbriae
and its expression is phase variable. Transcriptional studies were
performed using two lineages derived from AAEC198A and
AAEC374A strains, which carry the same fimA-lacZ operon fusion
in the chromosome. The AAEC374A derivatives CBP374 (wt) and
CBP375 (Dcrp) are phase variation deficient due to mutations in
the fimB and fimE genes (encoding the site-specific recombinases)
and have the invertible element locked in the ON orientation.
Such strains were used to monitor the transcriptional activity of
the fimA promoter. The AAEC198A derivatives CBP198 (wt) and
CBP199 (Dcrp) are phase variation proficient and consequently,
the fimA expression monitored using these strains integrates both
the percentage of fim-expressing cells (phase variation) and the
activity of the fimA promoter.
Using strains CBP198 and CBP199, a clear fimA up-regulation
was observed in the crp background as compared with wt (Fig. 1A),
indicating that CRP-cAMP represses type 1 fimbriation at the
transcriptional level, consistent with the agglutination data
(Table 1). On the other hand, when using CBP374 and CBP375
strains (Fig. 1B), a significantly lower fimA promoter activity was
detected in the crp mutant, thereby suggesting that CRP-cAMP
stimulates fimA promoter activity itself. Having in consideration
that CRP activity is strictly dependent on its co-factor cAMP, in-
frame cya deletion mutant strains (cAMP-deficient strains) were
created and compared with isogenic crp and wt strains. The effect
of the cya mutation on fimA expression resembled the one observed
in the crp strain (Fig. 1A and 1B). Moreover, restoration of CRP-
cAMP activity in crp and cya derivatives by using either the low
copy number plasmid pCBP68 (pLG338-crp) or external addition
of cAMP, respectively, restored fimA expression to wt levels (Fig. 1A
and 1B). Taken together, we may conclude that CRP-cAMP has a
dual role in the transcriptional expression of type 1 fimbriae: i) to
stimulate transcription of the fimA promoter in phase-ON-cells
and, ii) to repress the overall type 1 fimbriae expression.
A response in the expression of type 1 fimbriae upon addition of
exogenous cAMP was reported in static cultures of different cya
derivative strains [35]. However, the response was divergent in
different bacterial strains. The physiological heterogeneity in static
cultures might be the cause of the strain-dependent variation
detected. Our experiments using shaken cultures growing under
uniformly aerated conditions gave identical results with all the
strains used. Moreover, an increased fimA transcriptional expres-
sion in a CRP-cAMP deficient strain could be extracted from a
microarray dataset on the effect of the crp mutation on the global
pattern of expression in E. coli [10], consistent with our results.
To further probe into the dual role of CRP-cAMP in fimA
expression, the effect of rapid restoration of CRP activity by
addition of cAMP to cya strains was studied. When using early log
phase cultures of the phase variation proficient strain CBP198 and
its cya counterpart (Fig. 1C), the exposure to cAMP during one
hour period did not significantly alter the expression of fimA when
compared to the expression in control cultures (no addition of
cAMP). However, a significant rapid alteration in expression
(p=0.036 after 20 minutes) as a response to the addition of cAMP
was detected when using the phase variation deficient strains
CBP374 (wt) and CMM374 (Dcya) (Fig. 1D). The differences in the
kinetic of the response suggest that the dual role of CRP-cAMP on
fimA expression might be achieved by distinct mechanisms: a direct
stimulation of the fimA promoter activity and an indirect role in the
overall negative effect of CRP-cAMP on type 1 fimbriae
expression.
CRP-cAMP affects phase variation of type 1 fimbriae
So far, we have described that CRP-cAMP deficiency causes: i)
a higher degree of type 1 fimbriation, ii) an increase in the
expression of type 1 fimbriae in phase variation proficient strains,
and iii) a reduction in fimA promoter activity in phase variation
deficient strains. These results suggest that the percentage of
fimbriated cells (ON-cells) in both crp and cya mutant strains is
elevated when compared to wt, causing the overall increase in fimA
expression. To test this prediction, the percentage of ON-cells in
the population was monitored by plating cultures of the phase
variable fimA-lacZ reporter strains on indicator plates containing
X-gal. As predicted, a significant increase in the percentage of
ON-cells in both the crp and cya mutant strains was observed
(Fig. 2A). A quantitative PCR based method was validated (see
Materials and Methods and Fig. S1) and used to detect and
quantify the subpopulations having the invertible element either in
the ON or in the OFF orientation [40]. Consistent with the results
obtained from indicator plates, a significantly higher percentage of
ON-cells was found for CMM198 (Dcya) as compared to CBP198
(wt) (Fig. 2B). Moreover, the cya deficiency was chemically
complemented by addition of exogenous cAMP in the culture
medium. The effect of CRP-cAMP deficiency in the switching
between the ON and OFF orientation was further corroborated
when in vivo switching frequencies were measured (see below).
Similar results were obtained when using the reporterless and type
1 fimbriation-proficient strain MG1655 and its cya mutant
derivative (Fig. 2B), thereby excluding the possibility that the
lacZYA DNA sequence present in the reporter strains might affect
the CRP-mediated effect on phase variation. Moreover, when
derivatives of the uropathogenic isolate J96 were used, a significant
increase in the percentage of ON-cells was detected in crp
derivatives. While most of the cells in the wt population were in
the OFF orientation under the culture conditions used, a
subpopulation of cells with the invertible element in the ON
orientation was clearly detected in the mutant derivative (Fig. 2C).
To confirm these results, the level of fimA transcript in cultures of
J96 and its derivative J96crp were quantified by Northern blot
analysis (Fig. 2D). A 2.4-fold increase in fimA transcript was
CRP-cAMP Regulation of Type 1 Fimbriae
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obtained when using fimA-lacZ reporter strains (Fig. 1A).
The drop in fimA expression in CRP-cAMP deficient strains
carrying mutations in fimB fimE (Fig. 1B) was assumed to indicate a
stimulatory effect of CRP-cAMP on fimA promoter activity.
However, it could also be a consequence of an alteration of the
percentage of ON-cells by the action of some alternative FimB/
FimE-like recombinase, as described for several E. coli strains [43].
As depicted in Fig. 2E, OFF-cells were not observed in cultures of
strains CBP374 (wt), CBP375 (Dcrp) and CMM374 (Dcya), thereby
ruling out the involvement of alternative recombinases, which is
consistent with the fact that no genes for such enzymes are detected
in the MG1655 genome [43]. Taken together, our results suggest
that CRP-cAMP acts on the phase variation process by causing a
decrease in the percentage of fimbriated cells in the population.
Physiological implications of the CRP-cAMP–mediated
regulation of type 1 fimbriation
Type 1 fimbriation is growth phase dependent [31,32]. The fimA
expression profile throughout the growth curve was studied using
the strains CBP189 (wt) and CPB199 (Dcrp). As previously
described, fimA expression in wt cultures was low in the early
growth stages, increased in the middle of the logarithmic phase, and
stayed constantly high throughout stationary phase (Fig. 3A). In
contrast, fimA expression in the crp mutant peaked during early
logarithmic phase and then dropped down to almost wt levels
during late-logarithmic phase. Consistent with the transcriptional
data, a larger difference in the semi-quantitative phenotypic
determination of type 1 fimbriae expression (MSYA) was observed
withmid-log phase cultures of the wt and crp derivatives of MG1655
(1/2 versus 1/8, respectively) when compared to stationary phase
cultures (1/4 versus 1/8, Table 1). The analysis of fimA expression
through the growth curve suggests that CRP-cAMP represses type 1
fimbriation in actively growing cells, while during growth arrest, the
repression is released and other global regulators such as RpoS and
ppGpp assume the control[31,32]. This finding is also in agreement
with the described growth phase-dependent levels of CRP-cAMP in
the cell. As assessed by Northern blot analysis, crp transcriptional
expression is high in early exponential phase and significantly
reduced in stationary phase [44].
A well-described factor that alters the intracellular levels of
CRP-cAMP is carbon source availability, e.g. the presence of
glucose causes a significant reduction [6,7]. The effect of glucose
on the expression of type 1 fimbriae was monitored. A modest but
Figure 1. Effect of CRP-cAMP deficiency on the expression of the fimA gene. (A–B) fimA expression was monitored by measuring ß-
galactosidase activity from a chromosomal transcriptional fimA-lacZ fusion in either phase variation proficient (A) or phase variation deficient (B)
strain backgrounds. For complementation purposes, plasmid pCBP68 (crp
+) carrying the crp gene in the vector pLG338 (v.c.) was used. Bacterial
cultures were grown in LB medium at 37uC to mid-log phase. Black bars represent values derived from cultures grown without cAMP and white bars
represent values obtained from cultures grown in presence of 5 mM cAMP. Strains used in A: CBP198 (wt), CBP199 (Dcrp), and CMM198 (Dcya); Strains
used in B: CBP374 (wt), CBP375 (Dcrp), and CMM374 (Dcya). (C–D) Effect of addition of 5 mM cAMP (open symbols) on fimA expression in either phase
variation proficient (C) or phase variation deficient (D) strain backgrounds. Bacterial cultures were grown in LB medium at 37uCt oa nO D 600nm of 0.05
before the addition of cAMP. As controls, cultures with no addition of cAMP (filled symbols) were used. Strains used in C: CBP198 (wt, squares) and
CMM198 (Dcya, triangles). Strains used in D: CBP374 (wt, squares) and CMM374 (Dcya, triangles). All results shown are the mean values and standard
deviations from three independent experiments.
doi:10.1371/journal.ppat.1000303.g001
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be observed when CBP198 (wt) cultures were grown in M9-
glucose medium compared with cultures grown in M9-glycerol
(Fig. 3B). The stimulatory effect of the presence of glucose on
transcriptional expression of type 1 fimbriae was also observed by
microarray analysis on the effect of glucose in the general
expression pattern in E. coli [45].
CRP-cAMP deficient strains have a significant growth defect
compared to the wt (i.e: 89 and 34 minutes generation time in LB
for CBP199 and CBP198, respectively), which might raise the
question whether the increased type 1 expression in the crp strains
is merely due to the growth alterations. However, growth in media
that significantly increases the growth rate of the crp strain, i.e. LB
medium containing glucose (32 and 48 minutes generation time
for CBP198 and CBP199, respectively), did not alter the difference
in the expression of type 1 fimbriae between the wt and the crp
strains (data not shown), suggesting that the CRP specific effect on
type 1 fimbriae expression is not coupled to the growth rate.
CRP-cAMP affects the FimB-mediated OFF to ON switch
both in vivo and in vitro
The reported increase in the percentage of ON-cells in the
CRP-cAMP deficient strains could be achieved either by
stimulating the OFF to ON inversion (exclusively catalyzed by
FimB) or by causing the opposite effect on the ON to OFF
inversion (mainly catalyzed by FimE). To further dissect the role of
CRP-cAMP in the recombination event, the percentage of ON-
cells in wt and cya derivative strains expressing either FimB
(AAEC370A, fimE) or FimE (AAEC261A, fimB) was determined
(Fig. 4A). In the FimB proficient strains (fimE), a significant
increase in the percentage of ON-cells was detected in the strain
lacking CRP-cAMP (16% in cya versus 4% in wt). However, in
FimE proficient strains (fimB), consistent with published results
[46], all cells were in the OFF orientation independently of the
presence or absence of the CRP-cAMP complex. These results
suggest that CRP-cAMP is directly or indirectly affecting the
FimB-mediated inversion. To corroborate these data, in vitro
recombination assays were performed using template plasmids as
recombination substrate in bacterial extracts of cya and cya
+ strains
overexpressing either FimB or FimE. The induction of the
synthesis of the recombinases in cultures of the cya and cya
+
strains provided apparently identical amounts of the enzymes in
the extracts of both strains as determined by Coomassie-stained
SDS-PAGE (Fig. S2). When FimB-mediated OFF to ON inversion
was monitored (Fig. 4B), recombination occurred with both cya
and wt extracts in the presence of FimB. However, a remarkable
3-fold higher percentage (p=0.003) of invertible fragments in the
Figure 2. The percentage of fimbriated cells in the population is increased in crp and cya strains. (A) The percentage of fimA-expressing
cells in presence (white bar) or absence (black bars) of 5 mM cAMP was determined by the indicator plate assay (see Materials and Methods) using
mid-log phase cultures of the strains CBP198 (wt), CBP199 (Dcrp) and CMM198 (Dcya). Mean values and standard deviations from three independent
experiments are shown. (B) Quantification of the percentage of ON-cells in bacterial populations by a PCR-based assay. Cultures of wt and cya
derivatives of strains CBP198 and MG1655 were grown to mid-log phase in presence (white bars) or absence (black bars) of 5 mM cAMP. Mean values
and standard deviations of three independent experiments are shown. (C) ON-OFF diagnostic of mid-log phase cultures of the J96 strain and its crp
derivative; the arrowhead highlights the fragment corresponding to ON-cells detected in the J96crp samples. (D) Northern hybridization of total RNA
extracted from mid-log cultures from strains J96 (wt), J96crp (Dcrp), VL751 (Dfim), and AAG42 (Dlrp) with specific probes for fimA, fimB, lrp, and 16S
rRNA as indicated. (E) ON-OFF diagnostic of duplicated cultures of the phase variation deficient strains CBP374 (wt), CBP375 (Dcrp), and CMM374
(Dcya). A control showing the band pattern of an OFF population was included for comparison. The pictures in panels C and E are electronically
inverted images of ethidium bromide stained acrylamide gels.
doi:10.1371/journal.ppat.1000303.g002
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when compared with wt extracts. On the other hand, FimE-
mediated inversion from the ON to the OFF state did not seem to
be affected by a mutation in the cya gene (Fig. 4C). The FimB
recombinase can also catalyze the switch from ON to OFF.
However, no effect of CRP-cAMP on the FimB-mediated ON to
OFF inversion was detected when in vitro recombination assays
with DNA template in the ON orientation were performed (data
not shown). Altogether, our in vitro studies corroborate the results
obtained in vivo and suggest that the CRP-cAMP complex
specifically affects the FimB-mediated recombination event from
the OFF to the ON orientation. Supporting this conclusion, in vivo
switching frequency estimations indicated that the OFF to ON
switching rate was significantly increased in strain CBP199 (Dcrp)
as compared with CBP198 (wt) (1.1610
24 and 1.4610
22 per cell
and generation in wt and mutant, respectively), while no
significant effect was observed in the ON to OFF switching
(1.0610
26 and 1.6610
26 per cell and generation in wt and
mutant, respectively). Also supporting our results, it was reported
that the FimB-mediated switching frequency from OFF to ON is
3-fold higher in the presence of glucose (i.e. reduced intracellular
levels of CRP-cAMP) than in the presence of glycerol [24].
Although higher expression of fimB was observed in crp
derivatives as compared to wt counterparts in both J96 and
MG1655 strains (Fig. 2D and data not shown), the in vitro data,
where the recombinases were overexpressed to the same degree in
both extracts, suggest that the enhanced OFF to ON switching in
absence of CRP-cAMP is not strictly dependent on the levels of the
FimB recombinase. To further test this hypothesis, in vivo
experiments were performed under conditions of constitutive fimB
expression using plasmid pPKL9, which contains the fimB gene
under the control of the tet promoter (Fig. 4E). Control
experiments by Northern blot analyses verified that the fimB
expression levels from plasmid pPKL9 were essentially identical in
CRP-cAMP proficient and deficient genetic backgrounds (data not
shown). The percentage of ON-cells in cultures of J96 derivatives
constitutively expressing fimB (carrying plasmid pPKL9) was
significantly elevated in the CRP-cAMP deficient strain as
compared with wt, yielding a 50% higher percentage of ON-cells.
Comparable results were obtained when using MG1655 derivative
strains (data not shown). Altogether, our results both in vivo and in
vitro indicate that the CRP-cAMP complex has a negative effect on
the switching process independently of the intracellular concen-
tration of the FimB recombinase.
CRP-cAMP represses type 1 fimbriation by an indirect
mechanism
Two possible mechanisms by which CRP-cAMP affects the
FimB-mediated switch should be considered: either CRP-cAMP
can directly interact with the invertible DNA fragment repressing
the OFF to ON switch, or the effect of CRP-cAMP may be
indirect.
The slow response when adding exogenous cAMP to CMM198
cultures (Fig. 1C) suggested that the role of CRP-cAMP in the
regulation of the phase variation occurs by an indirect mechanism.
Nevertheless, to establish whether CRP-cAMP might also be
directly involved in the switching process, in vitro recombination
assays were performed using extracts of the cya strain while restoring
CRP-cAMP activity by addition of increasing amounts of cAMP
(Fig. 5A). No obvious alteration in the FimB-mediated switch was
detected, strongly suggesting that CRP-cAMP does not directly
interact with the nucleoprotein complex that is the substrate for the
FimB recombinase. Accordingly, no effect was observed in the
outcome of in vitro recombination assays when purified CRP was
added to extracts obtained from a crp strain (data not shown).
Simultaneously, the possible binding of CRP-cAMP to various
DNA fragments spanning different regions of the fim determinant
was tested (Fig. S3A). No strong CRP binding was detected to any
of the DNA fragments tested. At most, a low affinity binding was
detected in case of the fragment containing the fimA promoter
(PCR7; Fig. S3B). However, when DNase I footprinting analysis of
this putative CRP binding site was performed, no binding was
observed (data not shown). It has been reported that CRP-cAMP
might bind to many low affinity binding sites along the E. coli
chromosome [47]. Although it is possible that such low affinity
CRP binding site(s) may exist in the fimA promoter region, our
experimental evidence (Fig. 5A) suggested that binding is not
required for the phase variation control. A possible involvement of
the putative CRP binding site(s) in the positive control of the fimA
promoter activity (Fig. 1B) will be further studied.
Inhibition of DNA gyrase activity mimics the effect of
CRP-cAMP on type 1 fimbrial phase variation
Recently, it has been shown that inhibiting the DNA gyrase
promotes the FimB-mediated inversion from OFF to ON and
therefore it was concluded that DNA supercoiling determines the
directionality of the FimB-mediated recombination [29,48]. DNA
gyrase is an enzyme that catalyses ATP-dependent DNA breakage,
strand passage and rejoining of double-stranded DNA (for a recent
review see No ¨llmann et al. [49]). DNA gyrase is involved in the
regulation of DNA topology, but also in other processes such as
replication or illegitimate recombination [50,51]. Remarkably, it
has been described that CRP-cAMP modulates the expression of
the gyrA gene encoding the DNA gyrase. In crp deficient strains,
low levels of gyrA expression and DNA gyrase activity, monitored
as alterations in the topology of plasmid DNA, were detected [52].
One may hypothesize that the CRP-cAMP mediated effect on the
FimB-recombination process could directly result from the low
levels of DNA gyrase activity detected in crp deficient strains. To
test this hypothesis, the effect of inhibiting the DNA gyrase in vivo
was analyzed in both wt (CBP198) and cya (CMM198) strains
Figure 3. Type 1 fimbriae expression profile in different growth
conditions. (A) fimA expression was determined by measuring ß-
galactosidase activity at various optical densities from cultures of the
fimA-lacZ reporter strains CBP198 (wt, black bars) and CBP199 (Dcrp,
white bars) in LB medium at 37uC. (B) Quantification of the percentage
of fimA-expressing cells in the population of strain CBP198 (wt) on
indicator plates. Cultures were grown to mid-log phase at 37uCi nM 9
minimal medium containing either glycerol (glyc.) or glucose (gluc.) as a
carbon source. Mean values and standard deviations from three
independent experiments are shown.
doi:10.1371/journal.ppat.1000303.g003
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gyrase inhibitor) in wt cultures caused a concomitant increase in
fimA expression, consistent with previously reported data [29,48].
Remarkably, the fimA expression level was essentially unaltered by
addition of novobiocin in cultures of the cya mutant strain. In
agreement with the hypothesis proposed, the novobiocin mediated
inhibition of the DNA gyrase caused an increase in the percentage
of ON-cells in the wt strain, but not in the cya derivative (Fig. 5C,
upper panel). Results that further corroborated our hypothesis
were obtained by inducing overexpression of DNA gyrase from
cloned gyrAB genes in the cya strain CMM198. Both repression of
fimA expression and reduction in the percentage of ON-cells were
detected (Fig. S4). Moreover, when fimE mutant derivatives were
used, thus only reflecting FimB-mediated inversion, an identical
response to novobiocin was observed, indicating that the
recombination process that was responsive to gyrase inhibition in
vivo is FimB-specific (Fig. 5C, lower panel). To rule out the
possibility that the lacZYA sequences present in the fimA-lacZYA
fusion might cause alterations in the regional DNA supercoiling
and consequently affect the phase variation, similar experiments
were performed using reporterless derivatives of strains MG1655
and J96. Similar results were obtained: i) an increase in the
percentage of ON-cells in the wt strains was observed after
addition of increasing novobiocin concentration (5-fold and 2-fold
increase with the highest concentration of novobiocin tested in
MG1655 and J96 strains, respectively), ii) the level of ON-cells was
not altered by novobiocin treatment in the CRP-cAMP deficient
derivatives, and iii) the percentage of ON-cells in the wt achieved
by novobiocin treatment was similar to the level detected in the
CRP-cAMP deficient derivatives (data no shown). It is noteworthy
that in all approaches (Fig. 5B and 5C) the presence of novobiocin
in sub-inhibitory concentrations did not significantly alter the
expression of fimA in the cya mutant strains, which is in agreement
with a low DNA gyrase activity in the CRP-cAMP deficient
background as a result of the low expression of the gyrA gene [52].
To corroborate the in vivo results obtained, in vitro analyses were
performed where increasing amounts of novobiocin were added to
the wt strain extract. A progressive increase in the OFF to ON
switching efficiency in vitro was observed (Fig. 5D), consistent with
our in vivo data and with previously reported data [29,48].
Moreover, the unaltered fimA expression in the cya mutant strain
by addition of novobiocin, together with the in vitro switching data,
indicates that the fimA promoter is indifferent to changes in the
DNA gyrase activity, in agreement with previous data [48].
The fact that inhibition of the DNA gyrase activity in vitro
stimulated the FimB-mediated recombination suggests an active
role of the DNA gyrase during the recombination process itself.
Altogether, our data provide evidence that the induction of type 1
Figure 4. The CRP-cAMP regulatory complex affects the FimB-mediated OFF to ON switch. (A) Determination of the percentage of ON-
cells in strains expressing either FimB (AAEC370A, fimB
+ fimE) or FimE (AAEC261A, fimB fimE
+) and their cya counterparts. The upper half of a
representative gel used for ON-OFF diagnostic is shown. The estimated percentage of ON-cells in the cultures (% ON) is indicated as mean values and
standard deviations in brackets of three independent experiments. (B) In vitro OFF to ON recombination assay in bacterial extracts either containing
FimB or being recombinase free. Bacterial extracts were obtained from strain NEC026 (fim, cya
+) and its isogenic cya mutant CMM026, transformed
with either an inducible fimB expression plasmid (pIB378, fimB+) or the vector control (pET11, fimB2). Extracts were mixed with the template plasmid
pJL-2 (fim invertible element in the OFF orientation). The orientation of the plasmid-encoded fim invertible element was determined after 3 h
incubation by using the PCR-based assay (see Materials and Methods). Results are provided in the bar diagram as percentage of invertible elements in
the ON orientation. The picture in the right part of the Figure illustrates an ethidium bromide stained gel from one of the experiments used to obtain
the data shown. (C) In vitro ON to OFF recombination assay in bacterial extracts either containing FimE or being recombinase free. A similar assay as
presented in B was performed. In this case, bacterial extracts were obtained from strain NEC026 (wt) or its isogenic cya mutant CMM026, transformed
with either an inducible fimE expression plasmid (pIB382, fimE+) or the vector control (pET11, fimE2). Extracts were mixed with the template plasmid
pMM36 (fim invertible element in the ON orientation) and analyzed as in B. In both B and C, mean values and standard deviations from four
independent experiments are shown. (D) Effect of CRP-cAMP deficiency in the percentage of ON-cells in cultures of strain J96 and its cya derivative
carrying either the plasmid pPKL9 (constitutive fimB expression, fimB OE+) or the vector control (pBR322, fimB OE2). The percentage of ON-cells was
quantified from cultures of two independent clones. In A and D, the image corresponds to the upper half of an ethidium bromide stained gel.
doi:10.1371/journal.ppat.1000303.g004
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process mediated by the alteration in DNA gyrase activity and
therefore can be mimicked by the specific inhibition of this
enzymatic activity by novobiocin. Moreover, our in vitro results
comparing OFF to ON switching between wt and cya mutant using
the same DNA template for both extracts (Fig. 4B and Fig. 5D)
demonstrated that the CRP-cAMP effect on phase variation is not
merely dependent on the initial supercoiling state of the fim
invertible element.
Lack of CRP-cAMP results in increased Lrp levels
Recombination at the fim invertible element requires Lrp, a
DNA bending protein that directly binds to specific sites within the
invertible element and stimulates DNA inversion [26]. Kelly et al.
[29] demonstrated that this binding activity of Lrp is required to
promote the FimB-mediated OFF to ON directionality observed
when the DNA gyrase was inhibited. The Lrp levels were
determined by immunoblot analysis of crp
+ and crp strains (Fig. 6A)
and the Lrp content detected was several fold higher in the crp
strains than in the crp
+ strains. These results suggest a possible link
between the CRP and Lrp regulons. Interestingly, a direct
demonstration of CRP dependent regulation of Lrp expression
has not been done, although two putative CRP sites have been
predicted in the promoter region of the lrp gene [53], suggesting a
possible direct regulation by CRP-cAMP. Additionally, CRP-
cAMP could act indirectly by positively regulating GadE, which
represses lrp expression [54,55]. Transcriptional studies have been
performed by Northern blot analysis of RNA from derivatives of
MG1655 and J96 (Fig. 2D). An increase in the level of the lrp
transcript in the crp derivatives was detected as compared with wt
(2.5 and 1.7- fold in MG1655 and J96 derivatives, respectively),
suggesting a role for CRP-cAMP in the control of lrp transcription,
Figure 5. Insights on the mechanism of action of the CRP-cAMP complex in vivo and in vitro. (A) Effect of the addition of cAMP during in
vitro OFF to ON recombination. Bacterial extracts were obtained from strains NEC026 (wt) or CMM026 (Dcya) transformed with the inducible fimB
expression plasmid (pIB378). Extracts were mixed with the template plasmid pJL-2 in absence or presence of increasing amounts of cAMP (1 to
50 mM final concentration). Mean values and standard deviations of three independent experiments are shown. (B) Effect of increasing amounts of
the gyrase inhibitor novobiocin on fimA expression. ß-galactosidase activity was measured from strains CBP198 (wt, black bars) and CMM198 (Dcya,
white bars) grown to mid-log phase in LB medium supplemented with 0, 6.25, 12.5, and 25 mgm l
21 novobiocin. Mean values and standard
deviations from two independent experiments are shown. (C) Effect of DNA gyrase inhibition on the orientation of the fim invertible element in vivo.
Upper panel: ON-OFF diagnostic of the samples used in Fig. 5B, representing the strain CBP198 (fimB
+ fimE
+) and its cya derivative CMM198 grown in
presence of novobiocin (concentrations as indicated). Lower panel: ON-OFF diagnostic of the strain AAEC370A (fimB
+ fimE) and its Dcya derivative
CMM370A subject to the same growth conditions as in the upper panel. Both panels depict electronically inverted images of the upper half of
acrylamide gels after ethidium bromide staining. (D) Effect of DNA gyrase inhibition on FimB-mediated OFF to ON switching in vitro. Increasing
amounts of novobiocin (0, 50, 200 mgm l
21) were added to the in vitro recombination reactions. Bacterial extracts from strains NEC026 (wt, left panel)
or CMM026 (Dcya, right panel) transformed with the inducible fimB expression plasmid (pIB378) were used together with the template plasmid pJL-2.
Mean values and standard deviations in brackets of the estimated percentage of invertible elements in the ON orientation from four independent
experiments are given as numbers below each lane. The images correspond to ethidium bromide stained gels from a representative experiment used
to obtain the data shown.
doi:10.1371/journal.ppat.1000303.g005
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can not be ruled out. Further studies would be required to
characterize the CRP-cAMP dependent regulation of Lrp
expression.
Interestingly, when the levels of intracellular Lrp were
monitored in the same cultures as in Fig. 5B, again a differential
effect of the inhibition of the DNA gyrase in wt and cya strains was
observed (Fig. 6B). In a wt strain, the Lrp levels were strongly
elevated at the highest concentration of novobiocin, where the
amount of Lrp was apparently identical to the amount detected in
the cya strain in absence of novobiocin, which again might be
explained by the low DNA gyrase activity detected in the CRP-
cAMP deficient background [52]. We tested whether increased
levels of Lrp by itself would cause an alteration in the FimB-
mediated switching process. Our results clearly indicate that Lrp
overexpression per se did not result in any significant changes in the
percentage of ON-cells when no alteration in DNA gyrase activity
was induced (Fig. 6C).
Concluding remarks
The expression of type 1 fimbriae implies the allocation of an
important part of the asset of the bacterial cell for the production of
those proteinaceous appendages, as considerable amounts of energy
and amino acids are needed for their synthesis. A tightly regulated
expression of such organelles is therefore expected. Considering the
important metabolic effort performed by the bacterial cells
committed to be fimbriated, regulation by phase variation can be
seen as a selective advantage for the bacterial population, in
addition of providing phenotypical heterogeneity in an otherwise
genetically homogeneous population. In previous works, we have
shown that the expression of type 1 fimbriae is stimulated when
intracellular levels of the stringent response alarmone ppGpp are
raised [32,56]. The level of ppGpp in the cell increases under amino
acid starvation and energy stress [57]. In this report, the role of
CRP-cAMP,a regulatorycomplexthat is associated withtheenergy
state of the cell, has been included in the extensive list of regulatory
networks controlling type 1 fimbriation.
Interestingly, many of the global regulators that affect type 1
fimbriae expression, such as H-NS, RpoS, Lrp, and now CRP-
cAMP, have been shown to interplay among each other, thereby
orchestrating gene regulation cascades in response to the growth
conditions [58]. From our studies, we can conclude that CRP-
cAMP is a major regulator of fimbriation during the exponential
growth phase (Fig. 3A) and is required to maintain the growth
expression profile of type 1 fimbriae. We dissected the initial
observation that the crp derivatives of J96 showed an increased
ability to agglutinate yeast cells and conclude that CRP-cAMP
represses type 1 fimbriation, as schematically shown in Fig. 7, by
the recently described mechanism of switching directionality
established by the activity of the DNA gyrase and the presence
of Lrp [29], thereby affecting FimB-mediated OFF to ON
switching. Remarkably, CRP-cAMP inhibited FimB-mediated
recombination at a template plasmid isolated from a crp
+
background, indicating that the regulatory effect does not merely
depend on the supercoiling state of the DNA and thereby
suggesting an active role of the DNA gyrase in the OFF to ON
recombination event. Interestingly, CRP-cAMP has a dual effect
on type 1 fimbriation by repressing phase variation and promoting
promoter activity. Further studies will be required for fully
understanding the underlying mechanisms by which CRP-cAMP
affects both levels of regulation of type 1 fimbriation.
In Salmonella, crp cya mutants are avirulent in a mouse model
[59] and it has been reported that the crp and the cya genes are
strongly repressed during infection of macrophages [60]. More-
over, it has been observed that DNA becomes more relaxed when
bacteria are growing in certain intracellular environments and
consequently the expression of those genes that are required for
intracellular survival is induced [61]. Therefore, CRP-cAMP
might be involved in controlling Salmonella virulence in a pathway
that includes DNA supercoiling and the sensing of environmental
conditions as previously proposed [62].
It is well described that CRP and cAMP levels are affected by
environmental conditions such as glucose availability and osmolarity
[6,7]. Interestingly, such environmental conditions also affect DNA
topology in E. coli in a DNA gyrase dependent manner [63,64]. The
linkbetweenCRP-cAMPmediatedregulationofgeneexpressionand
DNA gyraseactivity might represent a specialized signal transduction
pathway that senses the metabolic and energetic status of the cell. It
can not be ruled out that in this regulatory pathway others factors
such as the FIS protein might be involved. FIS has been proposed
Figure 6. Induction of Lrp in a CRP-cAMP deficient background.
(A) Lrp levels in different genetic backgrounds. Whole bacterial cell
lysates of the strains CBP198 (wt), CBP199 (Dcrp), CBP199/pLG339
(Dcrp/v.c.), CBP199/pLG339-CRP (Dcrp/crp), and AAG42 (Dlrp) were
subjected to immunoblot analyses using Lrp-specific antiserum.
Numbers below each lane represent the average of the signal intensity
from three independent experiments relative to the corresponding wt
value (set as one). (B) Analysis of Lrp levels in whole cell lysates of strain
CBP198 (wt) and CMM198 (Dcya) grown in the presence of novobiocin
at the indicated concentrations (same bacterial cultures as in Fig. 5B).
(C) Effect of overexpression of lrp on the percentage of ON-cells.
Cultures of strain CBP198 transformed with a plasmid that carries the lrp
gene under the inducible Para-promoter (pAAG6) were grown to mid-
log phase in presence of the indicated concentrations of arabinose. The
induced levels of lrp were assessed by immunoblotting using Lrp-
specific antiserum. Simultaneously, quantification of the percentage of
ON-cells in the populations was performed by using the PCR-based
method. The lower image corresponds to the upper half of a
representative gel used for ON-OFF diagnostic; the results are given
as numbers below each lane.
doi:10.1371/journal.ppat.1000303.g006
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DNA supercoiling. Interestingly, CRP-cAMP modulates fis expres-
sion [65]. Supporting this model, a correlation between the sensitivity
to catabolite repression and to gyrase inhibitors has been observed
earlier for different metabolic operons. Hence, inhibition of DNA
gyrase activity represses the expression of several CRP-cAMP
sensitive genes (three maltose operons, the lactose and galactose
operons, and the tryptophanase gene), whereas CRP-cAMP
independent genes such as threonine and tryptophan operons were
insensitive to DNA gyrase inhibitors [66,67]. We can consider a
scenario where disadvantageous environmental conditions, which are
sensed by the bacterial cells as low rate of energy flow in the cell, are
transduced by different pathways (CRP-cAMP regulon, ppGpp
regulon), inducing survival strategies including cell fimbriation. The
fact that the highly energy-consuming process of fimbriation is
stimulated in conditions of starvation highlights the putative selective
advantage represented by the ability of expressing type 1 adhesins,
which promotes important virulence properties such as biofilm
formation and colonization of host mucosa.
The physiological relevance of the CRP-cAMP-mediated
signaling pathway controlling type 1 fimbriation needs to be further
explored. Nevertheless, the modulation of type 1 fimbriation
mediated by glucose availability may provide a possible explanation
to the reported observation that diabetic patients commonly are
highly susceptible to urinary tract infections [68]. The presence of
an unusual high concentration of glucosides in the urine of those
patients may cause a reduction in the intracellular level of CRP-
cAMP in the bacterial cell. This could result in a concomitant
increase in type 1 fimbriation which, in turn, would raise the
probability of colonization of the urinary tract.
Materials and Methods
Bacterial strains, plasmids, and growth conditions
All strains and plasmids used in this study are listed in Table 2.
Strains were grown to mid-log phase (corresponding to an
OD600nm of around 0.5) with vigorous shaking (200 rpm) at
37uC in Luria Bertani (LB) medium [69] or in M9 medium [70]
supplemented with either 0.4% glycerol or 0.4% glucose, unless
otherwise stated. For mannose-resistant haemagglutination
(MRHA), bacteria were grown in CFA (1% casaminoacids,
0.15% yeast extract, 0.05% MgSO4, 0.005% MnCl2). For
mannose-sensitive yeast agglutination (MSYA), bacteria were
grown in different culture media: TBA (1% tryptone, 0.5% NaCl,
1.5% agar), TSA (1.5% trypticase peptone, 0.5% phytone
peptone, 0.5% NaCl, 1.5% agar) and CFA. When necessary, the
following antibiotics were used: tetracycline (12.5 mgm l
21),
carbenicillin (50 mgm l
21), kanamycin (25 mgm l
21) and chloram-
phenicol (15 mgm l
21). When indicated, cyclic AMP was added in
a final concentration of 5 mM. To study type 1 fimbriae
expression, cultures of the different strains were always inoculated
using colonies showing an OFF (non-fimbriated) phenotype. When
fimA-lacZ fusion derivatives were used, OFF-colonies could be
identified on X-gal plates (white colonies). In reporterless strains
(MG1655 and J96 derivatives), the fimbriation state of the
inoculum was estimated from the colony morphology, since ON-
colonies are small and convex, while OFF-colonies are large and
flat, as described by Blomfield et al. [71].
Genetic techniques
Standard molecular manipulations were performed according
to Sambrook and Russel [70]. The cya deletion mutant (D21–259)
and Dcya::Km
r deletion mutant (D21–259::Km
r) were created by
allelic exchange as described by Link et al. [72]. The deletion
mutant and Km
r deletion mutant were verified by PCR
amplification using primers cya-A and cya-D, and cya-up and
cya-D, respectively. Gene alleles were introduced by phage P1-
mediated transduction [73] using the following donor strains;
BEU742 for Dcrp39 (Tc
r), SS5357 for Dlrp::Tc
r and CMM2 for
Dcya::Km
r. Derivatives crp
+ and Dcrp39 were initially selected by
colony size and confirmed by PCR using primers CRP1 and
CRP3. The plasmid pAAG6 was constructed by cloning a PCR-
amplified fragment spanning the lrp gene between the EcoRI-
SmaI sites of pBAD30. The PCR fragment was generated using
the primers lrp-1 and 64 and MG1655 as template. All primers
used are specified in Table S1.
Mannose-resistant haemagglutination (MRHA)
Bacteria were grown on CFA agar plates. Bacterial cell
suspension in PBS containing 3% (w/v) mannose (methyl a-D-
mannopyranoside, Sigma) were prepared and adjusted to an
OD600 nm of 5. MRHA was tested using suspensions from human
(agglutination-positive with P-fimbriae) and dog (agglutination-
positive with Prs-fimbriae) erythrocytes (8%, v/v) in PBS, giving
identical results. The erythrocytes and bacterial suspensions were
mixed in proportion 1:1 (v/v) on a glass-slide. Presence of
aggregates was considered as agglutination positive.
Fimbrial antisera agglutination
Bacteria were grown on CFA agar plates. Bacterial colonies
were mixed with 10 mlo f2 0 6 diluted antisera. Two types of
antisera were used, pPAP5 and pPAP60 (originally obtained
against P and Prs fimbriae, respectively) that strongly cross-react
and mediate agglutination through both types of fimbriae [74].
Presence of aggregates was considered as agglutination positive.
Mannose-sensitive yeast agglutination (MSYA)
Bacteria were grown on LB plates overnight at 37uC, washed in
PBS and resuspended to an OD600nm of 5. Yeast cells (Saccharomyces
cerevisiae) were washed and resuspended in PBS to an OD600nm of
5. The suspensions were mixed in a 1:1 (v/v) ratio on a glass-slide
placed on ice. After 30 min, the presence of aggregates as sign for
Figure 7. Schematic model of action of the CRP-cAMP complex
on the regulation of type 1 fimbriation. The integration of
different environmental signals modify the levels of the CRP-cAMP
complex which affects the phase variation of type 1 fimbriae by altering
the FimB-mediated directionality of the OFF to ON recombination
event. Based on our results, a model is proposed where a stimulation of
the DNA gyrase activity by CRP-cAMP [52] would repress the FimB-
mediated recombination from the OFF to the ON orientation by a
mechanism that requires the presence of Lrp [29]. In this work, a
repressing effect of CRP-cAMP on the expression of Lrp and a
stimulatory effect of CRP-cAMP on fimA promoter activity have also
been described. Green arrows indicate stimulatory effects, whereas red
lines indicate repressing effects.
doi:10.1371/journal.ppat.1000303.g007
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Semi-quantitative analysis was performed as described before [32].
Motility assay
Overnight cultures were diluted in LB and adjusted to an
OD600nm of 1.0 and 4 ml were put on semi-solid LB medium
containing 0.3% agar and incubated at 37uC.
Measurement of b-galactosidase activity
The b-galactosidase assay was performed as described by Miller
[75]. Data presented represent average values and standard
deviations of duplicate measurements from at least three
independent experiments.
Determination of the percentage of fimA-expressing cells
on indicator plates
To monitor the orientation of the fim invertible element in
strains carrying a chromosomal fimA-lacZ fusion, indicator plates
containing X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyra-
noside) were used as previously described [24]. Cells having the
fim invertible element in the ON orientation give rise to blue
colonies, whereas those cells having it in the OFF orientation
exhibit white color.
Determination of the switch orientation and
quantification of the percentage of ON-cells using a PCR
based assay
The orientation of the invertible DNA fragment can be
determined using a molecular approach described previously
[32,40]. In brief, a 602-bp DNA fragment containing the fim
invertible element was PCR amplified using primers 2535 and
3137, HinfI restricted and analyzed on TBE-acrylamide-gels.
Depending on the orientation of the fim invertible element, this
method generates different sized fragments (484 and 118 bp when
in the ON orientation, 402 and 200 bp when in the OFF
orientation).
Quantification of the percentage of ON-cells in a specific
sample was performed as described by Aberg et al. [32]. To prove
the reliability of this method, calibration experiments were
performed in triplicate using templates from strain CBP374 (a
100% ON-cells sample) and CBP198 (representing the OFF-cells
samples). Both strains were grown to the same optical density and
mixed such that the fraction of ON-cells in the template varied
from 0 to 100%. PCR amplification, HinfI digestion and gel
electrophoresis were performed as described above. The applica-
bility of this method to quantify the percentage of ON-cells in
bacterial populations was evidenced by a linear correlation
[regression coefficient (R
2) of 0.998] between the percentage of
ON-cells in the sample and the intensity of the bands (Fig. S1).
Since the invertible element in CBP198 is not completely in the
OFF orientation, the intensity derived from ON-cells in the
‘‘100%-OFF’’ sample was subtracted from all intensity values.
RNA isolation and Northern analysis
Total RNA was extracted from mid-log cultures using the hot-
phenol method [76]. Contaminating DNA was removed by DNase
I (Roche Diagnostics) treatment for 1 h at 37uC, followed by RNA
cleanup using the RNeasy Mini kit (Qiagen). For Northern
analysis, 20 mg of total RNA were separated on a formaldehy-
de:agarose gel and transferred to Hybond-N membranes (Amer-
sham) by capillary blotting as described [77]. The membrane was
hybridized with
32P-labeled DNA-fragments corresponding to the
coding sequences of fimA, fimB, lrp, and rrnA, which were PCR
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pIB378 fimB under T7 promoter cloned into pET11 [79]
pIB382 fimE under T7 promoter cloned into pET11 [79]
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RT1&2 and 16S-RT1&2, respectively. After hybridization
overnight at 52uC, membranes were subsequently washed in 16
SSC-0.1% SDS for 15 min at room temperature and in 0.16
SSC-0.1% SDS for 15 min at 52uC. Autoradiograms were
obtained using StoragePhosphor screens (Molecular Dynamics),
which were scanned using the Storm Imaging System (Molecular
Dynamics).
Determination of FimB and FimE switching frequencies in
vivo
FimB and FimE-promoted switching frequencies were mea-
sured as previously described [24].
In vitro recombination assay
To perform FimB in vitro recombination assays, bacterial
extracts were obtained from cultures of the fim mutant strain
NEC026 and its isogenic cya mutant strain harboring the plasmid
pIB378 (fimB gene under the control of an IPTG inducible
promoter in pET11). fimB expression was induced with 0.4 mM
IPTG after the cultures grown in minimal MOPS [78] at 28uC
had reached an OD600nm of 0.15. Cells were harvested after 24 h
of induction at 28uC and processed as described [40,79]. As
control, extracts lacking FimB were obtained from cultures of the
same strains carrying the pET11 plasmid. To perform FimE in vitro
recombination assays, bacterial extracts were obtained from
cultures of the strain NEC026 and its isogenic cya mutant strain
transformed with the plasmid pIB382 (fimE gene under the control
of an IPTG inducible promoter in pET11). Cultures were
manipulated as described above. The in vitro recombination assay
was performed as described [40,79]. The resulting orientation of
the invertible element was analyzed after 3 h incubation at 37uC
using the PCR-based method described above.
Immunoblotting
Whole cell extracts from bacterial cultures were separated by
SDS-PAGE as described by Laemmli [80] using 15% polyacryl-
amide gels. Samples were transferred to PVDF membranes using a
semidry blotting apparatus. After blocking the membranes
overnight in Tris-buffered saline containing 0.1% Tween-20
(TBS-T) and 5% skimmed milk, membranes were incubated for
1 h at room temperature with 2,0006 diluted Lrp-specific
antiserum or 6,0006 diluted PapA-specific antiserum [38] in
TBS-T containing 5% skimmed milk. After 3615 min washes in
TBS-T, membranes were incubated for 1 h with 20,0006diluted
anti-rabbit immunoglobuline-horseradish peroxidase conjugate
(Dianova, Hamburg, Germany). After further washing, membranes
were developed using the enhanced chemiluminescence (ECL+) kit
(GE Healthcare) and analyzed on a Chemidoc System (BioRad)
equipped with the QuantityOneH Software for quantification.
Statistical analysis
Differences between average values were tested for significance
by performing an unpaired, two-sided Student’s t-test. The levels
of significance of the resulting p values are reported by the
following symbols: *=p,0.05; **=p,0.01; ***=p,0.001 and
n.s.=non-significant.
Supporting Information
Figure S1 Validation of the PCR based assay used for
quantifying the percentage of cells in the population with the
invertible element in the ON-orientation. Suspensions of CBP198
(OFF-template) and CBP374 (ON-template) cells were mixed in
the indicated ratios (0–100% ON-template). The HinfI restriction
pattern of the PCR amplified fragment containing the fim
invertible element is shown. The size (in base pairs) of the
different diagnostic ON and OFF fragments is indicated. Below
each lane, the results of quantification and calculation of the
percentage of ON-cells in the population in each sample according
to the described method are presented as mean values6standard
deviation of three independent calibration experiments.
Found at: doi:10.1371/journal.ppat.1000303.s001 (0.32 MB TIF)
Figure S2 Electrophoretic analysis of protein extracts used for
the in vitro recombination assays. Extracts from NEC026 (wt) and
CMM026 (cya) strains carrying the plasmids pET11 (vector
control), pIB378 (pET11 carrying the fimB gene) and pIB382
(pET11 carrying fimE) were obtained as described in materials and
methods. Proteins were separated by SDS-15% PAGE and
Coomassie stained. The bands representing the induced FimB
and FimE (right margin) and the molecular mass of relevant
protein markers (left margin) are indicated.
Found at: doi:10.1371/journal.ppat.1000303.s002 (0.44 MB TIF)
Figure S3 DNA-binding pattern of CRP at the fim regulatory
regions. A. Schematic representation of the fim determinant and
position of the promoters (P) of fimB, fimE, and fimA. Black
arrowheads represent the inverted repeats flanking the invertible
element. The relative positions of the PCR fragments used for the
gel mobility shift are depicted below. B. Gel mobility shift assay of
purified CRP protein (3 mM) and various PCR-amplified DNA
fragments (PCR1-5, and PCR7, here shown using OFF-cells as
template for amplification). In all panels, samples correspond to:
lane 1: no protein (cAMP present); lane 2: CRP protein with
20 mM cAMP (active form); lane 3: CRP protein without cAMP
(inactive form). Identical result was obtained when PCR7 fragment
was obtained from ON-cells as template. Recombinant CRP
protein was purified from strain pp6/pHA7 essentially as described
(Zhang et al., 1991). The PCR amplification and the mobility shift
assay were performed as described (Xia et al., 2000). - Zhang, X.P.,
Gunasekera, A., Ebright, Y.W., and Ebright, R.H. (1991) J.
Biomol. Struct. Dyn. 9: 463-473. - Xia, Y., Gally, D., Forsman-
Semb, K., and Uhlin, B.E. (2000) EMBO J. 19: 1450-1457
Found at: doi:10.1371/journal.ppat.1000303.s003 (0.41 MB TIF)
Figure S4 Effect of gyrA and gyrB overexpression on the
expression of type 1 fimbriae in a CRP-cAMP deficient strain.
A. fimA expression from strain CMM198 (cya) carrying the
plasmids pCA24N-gyrA and pRSFDuet-gyrB, which carry the gyrA
and the gyrB genes, respectively, under IPTG-inducible promoters,
was monitored in either the absence (2) or the presence (+)o f
IPTG. Bacterial cultures were grown in LB medium to mid-log
phase. IPTG was added at a final concentration of 0.015 mM
(condition that did not cause any deleterious effect on the bacterial
growth). Mean values and standard deviations from three
independent experiments are shown. B. ON-OFF diagnostic of
two of the bacterial cultures used in A. The panel depicts an
electronically inverted image of the upper half of acrylamide gel
after ethidium bromide staining; the arrowhead highlights the
fragment corresponding to ON-cells.
Found at: doi:10.1371/journal.ppat.1000303.s004 (0.10 MB TIF)
Table S1 Oligonucleotides used in this study.
Found at: doi:10.1371/journal.ppat.1000303.s005 (0.03 MB
DOC)
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